The faculty for this activity are listed below:
Giorgos Karakousis, MD (Planner, Moderator)
Abramson Cancer Center/University of Pennsylvania
Christina Angeles, MD (Planner, Moderator)
University of Michigan
David Ollila, MD (Planner, Presenter)
The University of North Carolina
Jonathan Zager, MD (Planner, Presenter)
Moffitt Cancer Center
Requirements for Earning Credit and Method of Participation
Estimated Time to Complete Activity
In accordance with the ACCME’s Accreditation Criteria, the Society of Surgical Oncology must ensure that anyone in position to control the content of this educational activity has disclosed all financial relationships with a commercial interest. All educational planners, authors, reviewers, and other individuals in a position to control or influence the content of this activity were required to disclose all financial relationships with any commercial interest that have occurred within the past 12 months. This includes the disclosure of financial relationships of a spouse or partner. The ACCME considers financial relationships to create conflicts of interest when individuals have both a financial relationship with a commercial interest and the opportunity to affect the content of CME about the products or services of that commercial interest. The ACCME defines a commercial interest as “any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients.” ACCME does not consider providers of clinical service directly to patients to be commercial interests.
The ACCME also requires that the Society of Surgical Oncology resolve any reported conflict of interest and ensure the educational content of this activity is vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. If you perceive bias while participating in this activity, please advise us of the circumstances when completing your post-activity evaluation form.
All identified conflicts of interests have been resolved.
Planners, Moderators and Faculty
Christina Angeles, MD has disclosed no financial relationships.
Giorgos Karakousis, MD has disclosed no financial relationships.
Tina Hieken, MD has disclosed the following financial relationships: Genentech – Research Grant, Research Support.
David Ollila, MD has disclosed no financial relationships.
Jonathan Zager, MD has disclosed the following financial relationships: Pfizer - Speakers Bureau; Sun Pharma - Speakers Bureau; Castle Biosciences - Consultant, Research Funding; Philogen - Consultant, Research Funding; Novartis - Advisory Board; Merck - Advisory Board; Sanofi Dash Regeneron - Advisory Board; Delcath - Grant Funding, Advisory Board, Research Funding; Amgen - Consultant, Research Funding; Provectus - Research Funding
Reviewers
Hans Schoellhammer, MD has disclosed no financial relationships.
John Hamner, MD has disclosed no financial relationships.
Staff
Patti Stella, CAE, CHCP, Director of Education, Society of Surgical Oncology, has disclosed the following financial relationships: Horizon Pharmaceutical PLC – Stocks; Biotech – Stocks.
The primary purpose of the Society of Surgical Oncology's enduring material is educational. Information, as well as technologies, products, and/or services, discussed are intended to inform participants about the knowledge, techniques, and experiences of specialists who are willing to share such information with colleagues. A diversity of professional opinions exists in the specialty, and the Society of Surgical Oncology disclaims any and all liability for damages to any individual using the materials and for all claims which may result from the use of information, technologies, products, and/or services discussed.
This educational activity may include discussions of unlabeled/unapproved uses of drugs or devices. Participants are advised to refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Opinions expressed in this educational activity are those of the expert contributors and do not necessarily represent the views of the Society of Surgical Oncology or any other organization associated with this activity.